retatrutide triple agonist gip glp-1 glucagon phase 3 2025 (Eli Lilly's GLP-1/GIP/Glucagon receptor agonist) just delivered the most impressive obesity + osteoarthritis data we've ever seen in the TRIUMPH-4 trial: Retatrutide Delivers 22.6% Weight Loss
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20



























